TDP-43 Immunoreactivity in Hippocampal Sclerosis and Alzheimer's Disease

Overview

Journal Ann Neurol

Specialty Neurology

Date 2007 May 1

PMID 17469117

Citations 492

Authors

Catalina Amador-Ortiz

Wen-Lang Lin

Zeshan Ahmed

David Personett

Peter Davies

Ranjan Duara

Neill R Graff-Radford

Michael L Hutton

Dennis W Dickson

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to determine the frequency of frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) in the setting of hippocampal sclerosis (HpScl) and Alzheimer's disease (AD) using immunohistochemistry for TAR DNA binding protein 43 (TDP-43), a putative marker for FTLD-U.

Methods: Initially, 21 cases of HpScl associated with a variety of other pathological processes and 74 cases of AD were screened for FTLD-U with TDP-43 immunohistochemistry. A confirmation study was performed on 93 additional AD cases. Specificity of TDP-43 antibodies was assessed using double-immunolabeling confocal microscopy, immunoelectron microscopy, and biochemistry.

Results: TDP-43 immunoreactivity was detected in 71% of HpScl and 23% of AD cases. Double immunostaining of AD cases for TDP-43 and phospho-tau showed that the TDP-43-immunoreactive inclusions were usually distinct from neurofibrillary tangles. At the ultrastructural level, TDP-43 immunoreactivity in AD was associated with granular and filamentous cytosolic material and only occasionally associated with tau filaments. Western blots of AD cases showed a band that migrated at a higher molecular weight than normal TDP-43 that was not present in AD cases without TDP-43 immunoreactivity.

Interpretation: These results suggest that as many as 20% of AD cases and more than 70% of HpScl cases have pathology similar to that found in FTLD-U. Whether this represents concomitant FTLD-U or is analogous to colocalization of alpha-synuclein and tau in AD, reflecting a propensity for codeposition of abnormal protein conformers, remains to be determined.

Citing Articles

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Thal D, Poesen K, Vandenberghe R, De Meyer S Mol Neurodegener. 2025; 20(1):33.

PMID: 40087672 DOI: 10.1186/s13024-025-00819-y.

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence.

Mitra J, Kodavati M, Dharmalingam P, Guerrero E, Rao K, Garruto R Acta Neuropathol Commun. 2025; 13(1):54.

PMID: 40057796 PMC: 11889789. DOI: 10.1186/s40478-025-01962-9.

TMEM106B deficiency leads to alterations in lipid metabolism and obesity in the TDP-43 knock-in mouse model.

Yang C, Lee G, Hao L, Hu F Commun Biol. 2025; 8(1):315.

PMID: 40011708 PMC: 11865606. DOI: 10.1038/s42003-025-07752-2.

TDP-43 Aggregate Seeding Impairs Autoregulation and Causes TDP-43 Dysfunction.

Mamede L, Hu M, Titus A, Vaquer-Alicea J, French R, Diamond M bioRxiv. 2025; .

PMID: 39990366 PMC: 11844547. DOI: 10.1101/2025.02.11.637743.

Detection of an Intermediate in the Unfolding Process of the N-Terminal Domain of TDP-43.

Marzi I, Pieraccini G, Bemporad F, Chiti F ACS Omega. 2025; 10(6):5616-5633.

PMID: 39989811 PMC: 11840787. DOI: 10.1021/acsomega.4c08617.

References

Giasson B, Forman M, Higuchi M, Golbe L, Graves C, Kotzbauer P . Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 2003; 300(5619):636-40. DOI: 10.1126/science.1082324. View

Ishizawa T, Mattila P, Davies P, Wang D, Dickson D . Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol. 2003; 62(4):389-97. DOI: 10.1093/jnen/62.4.389. View

Hebert L, Scherr P, Bienias J, Bennett D, Evans D . Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003; 60(8):1119-22. DOI: 10.1001/archneur.60.8.1119. View

Beach T, Sue L, Scott S, Layne K, Newell A, Walker D . Hippocampal sclerosis dementia with tauopathy. Brain Pathol. 2003; 13(3):263-78. PMC: 8095804. DOI: 10.1111/j.1750-3639.2003.tb00027.x. View

Snowden J, Neary D, Mann D . Frontotemporal dementia. Br J Psychiatry. 2002; 180:140-3. DOI: 10.1192/bjp.180.2.140. View

Togo T, Cookson N, Dickson D . Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol. 2002; 12(1):45-52. PMC: 8095958. DOI: 10.1111/j.1750-3639.2002.tb00421.x. View

McKhann G, Albert M, Grossman M, Miller B, Dickson D, Trojanowski J . Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001; 58(11):1803-9. DOI: 10.1001/archneur.58.11.1803. View

Knopman D, MASTRI A, Frey 2nd W, Sung J, Rustan T . Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 1990; 40(2):251-6. DOI: 10.1212/wnl.40.2.251. View

Hamilton R, Bowser R . Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol. 2004; 107(6):515-22. DOI: 10.1007/s00401-004-0843-1. View

10.

Lippa C, Dickson D . Hippocampal sclerosis dementia: expanding the phenotypes of frontotemporal dementias?. Neurology. 2004; 63(3):414-5. DOI: 10.1212/01.wnl.0000136241.71716.72. View

11.

Hatanpaa K, Blass D, Pletnikova O, Crain B, Bigio E, Hedreen J . Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology. 2004; 63(3):538-42. DOI: 10.1212/01.wnl.0000129543.46734.c0. View

12.

Lipton A, White 3rd C, Bigio E . Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol. 2004; 108(5):379-85. DOI: 10.1007/s00401-004-0900-9. View

13.

Kosaka K, Tsuchiya K, Yoshimura M . Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol. 1988; 7(6):299-305. View

14.

Lin W, Lewis J, Yen S, Hutton M, Dickson D . Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. Am J Pathol. 2003; 162(1):213-8. PMC: 1851123. DOI: 10.1016/S0002-9440(10)63812-6. View

15.

W Barker W, Luis C, Kashuba A, Luis M, Harwood D, Loewenstein D . Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002; 16(4):203-12. DOI: 10.1097/00002093-200210000-00001. View

16.

Duda J, Giasson B, Mabon M, Miller D, Golbe L, Lee V . Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol. 2002; 104(1):7-11. DOI: 10.1007/s00401-002-0563-3. View

17.

Josephs K, Dickson D . Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging. 2006; 28(11):1718-22. DOI: 10.1016/j.neurobiolaging.2006.07.010. View

18.

Greenberg S, Davies P . A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A. 1990; 87(15):5827-31. PMC: 54421. DOI: 10.1073/pnas.87.15.5827. View

19.

Okamoto K, Hirai S, Yamazaki T, Sun X, Nakazato Y . New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett. 1991; 129(2):233-6. DOI: 10.1016/0304-3940(91)90469-a. View

20.

Wightman G, Anderson V, Martin J, Swash M, Anderton B, Neary D . Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett. 1992; 139(2):269-74. DOI: 10.1016/0304-3940(92)90569-s. View